Hamilton Capital Partners (Canada)’s Bristol-Myers Squibb BMY Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.5M	Buy	130,247 +19,142	+17%	+$1.1M	0.22%	84
2026 Q1	$6.74M	Sell	111,105 -12,956	-10%	-$755K	0.23%	69
2025 Q4	$6.69M	Buy	124,061 +16,728	+16%	+$805K	0.25%	74
2025 Q3	$4.84M	Buy	107,333 +22,658	+27%	+$1.06M	0.2%	89
2025 Q2	$3.92M	Buy	84,675 +19,119	+29%	+$939K	0.2%	94
2025 Q1	$4M	Sell	65,556 -5,999	-8%	-$350K	0.26%	83
2024 Q4	$4.05M	Sell	71,555 -15,901	-18%	-$888K	0.3%	65
2024 Q3	$4.52M	Sell	87,456 -2,730	-3%	-$128K	0.39%	59
2024 Q2	$3.75M	Buy	90,186 +5,086	+6%	+$228K	0.4%	71
2024 Q1	$4.61M	Buy	+85,100	New	+$4.34M	0.56%	53

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s BMY Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, buying an estimated $1.1M and bringing the position to 130,247 shares worth $7.5M. The position accounts for 0.22% of the portfolio, ranked #84.

Hamilton Capital Partners (Canada) first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hamilton Capital Partners (Canada) held 130,247 shares of Bristol-Myers Squibb worth $7.5M as of Q2 2026.
Hamilton Capital Partners (Canada) bought 19,142 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.1M.
Bristol-Myers Squibb made up 0.22% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #84 holding.
Hamilton Capital Partners (Canada) first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.